The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting.
Lindsay Carol Overton
No relevant relationships to disclose
Christopher L. Corless
Research Funding - Life Technologies
Other Remuneration - Life Technologies
Manish Agrawal
No relevant relationships to disclose
Vasily J. Assikis
No relevant relationships to disclose
Nancy L. Beegle
No relevant relationships to disclose
Sibel Blau
No relevant relationships to disclose
Marc Chernoff
No relevant relationships to disclose
Stephen G. Divers
No relevant relationships to disclose
David H. Henry
No relevant relationships to disclose
Petros Nikolinakos
Employment or Leadership Position - Cancer Centers of Excellence (U)
Research Funding - Cancer Centers of Excellence
Other Remuneration - Cancer Centers of Excellence
Colleen Oliver
No relevant relationships to disclose
Eric Scott Schaefer
Employment or Leadership Position - Cancer Centers of Excellence (U)
Stock Ownership - CGCC
Frederick M. Schnell
Employment or Leadership Position - Cancer Centers of Excellence (U)
Stock Ownership - Central Georgia Cancer Care
Dennis Slater
No relevant relationships to disclose
Daniel Lewis Spitz
No relevant relationships to disclose
Vicki Tosher
No relevant relationships to disclose
Robert J. Green
Employment or Leadership Position - Cancer Centers of Excellence